Pancreatic Cancer Research

ResearcherRush University Medical CenterNo recent work listed

Usman Barlass

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5030717794. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 2 papers

Papers 5

  1. Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. First author DOI 10.1007/s11010-022-04377-5↗
  2. Correction to: Novel role of the Mu‑opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. First author DOI 10.1007/s11010-022-04400-9↗
  3. Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases. Co-author DOI 10.1371/journal.pone.0244285↗
  4. Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/biomedicines9070705↗
  5. Pancreatic Fat Infiltration Is Associated with a Higher Risk of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1159/000507457↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Faraz Bishehsari · 5 shared papers, 2020–2022 · strength 0.85
  2. Muhammad R. Haque · 3 shared papers, 2021–2022 · strength 0.54
  3. Andrew Armstrong · 3 shared papers, 2021–2022 · strength 0.54
  4. Ajaypal Singh · 1 shared paper, 2021 · strength 0.13
  5. Vishal Desai · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.